Abstract
Phosphatase and Tensin Homolog on chromosome Ten (PTEN) has emerged as a key protein that governs the response to kidney injury. Notably, renal adaptive repair is important for preventing acute kidney injury (AKI) to chronic kidney disease (CKD) transition. To test the role of PTEN in renal repair after acute injury, we constructed a mouse model that overexpresses PTEN in renal proximal tubular cells (RPTC) by crossing PTENfl-stop-fl mice with Ggt1-Cre mice. Mass spectrometry-based proteomics was performed after subjecting these mice to ischemia/reperfusion (I/R). We found that PTEN was downregulated in renal tubular cells in mice and cultured HK-2 cells subjected to renal maladaptive repair induced by I/R. Renal expression of PTEN negatively correlated with NGAL and fibrotic markers. RPTC-specific PTEN overexpression relieved I/R-induced maladaptive repair, as indicated by alleviative tubular cell damage, apoptosis, and subsequent renal fibrosis. Mass spectrometry analysis revealed that differentially expressed proteins in RPTC-specific PTEN overexpression mice subjected to I/R were significantly enriched in phagosome, PI3K/Akt, and HIF-1 signaling pathway and found significant upregulation of CHMP2A, an autophagy-related protein. PTEN deficiency downregulated CHMP2A and inhibited phagosome closure and autolysosome formation, which aggravated cell injury and apoptosis after I/R. PTEN overexpression had the opposite effect. Notably, the beneficial effect of PTEN overexpression on autophagy flux and cell damage was abolished when CHMP2A was silenced. Collectively, our study suggests that PTEN relieved renal maladaptive repair in terms of cell damage, apoptosis, and renal fibrosis by upregulating CHMP2A-mediated phagosome closure, suggesting that PTEN/CHMP2A may serve as a novel therapeutic target for the AKI to CKD transition.
Similar content being viewed by others
Introduction
Acute kidney injury (AKI) is a syndrome defined by rapid loss of renal function and occurs in ~10–15% of in-hospital patients, and >50% of patients admitted to the intensive care unit [1, 2]. AKI is mainly caused by ischemia/reperfusion (I/R) injury, sepsis, and nephrotoxic agents [1, 2]. Aside from its high mortality, AKI can trigger immediate kidney damage (referred to as acute kidney disease) or long-term damage (in the form of chronic kidney disease (CKD) and end-stage renal disease), both due to maladaptive repair [3,4,5]. Pathologically, AKI is mainly characterized by renal tubule epithelial cell damage and subsequent dysfunction and cell death [6, 7]. The relationship between AKI and CKD is determined by the severity of renal tubule damage; and if renal tubule damage is alleviated in the acute-injury stage and adaptive repair is facilitated, then tubular structure and function can be restored to normalcy. Notably, AKI experimental models detected altered autophagy an intracellular degradation process that is essential for physiological function and survival of renal tubular cells [8,9,10]. Nevertheless, whether and how autophagy flux works in the pathogenesis of renal I/R injury and repair remains controversial.
Phosphatase and Tensin Homolog on chromosome Ten (PTEN) is a critical tumor suppressor that possesses dual-specificity phosphatase. PTEN governs a variety of biological processes in both PIP3-dependent and PIP3-independent pathways, including genome maintenance, cell motility, proliferation, survival, and metabolism [11, 12]. Recent studies increasingly suggest that PTEN plays a prominent role in kidney diseases, especially diabetic kidney disease (DKD) and renal fibrosis [13, 14]. Indeed, overexpression of PTEN reportedly relieves renal fibrosis and slows CKD progression by suppressing phosphoinositide-3 kinase (PI3K)/Akt and transforming growth factor (TGF)-β-induced JNK signaling [15, 16]. In confirmation of this idea, we previously demonstrated that podocyte-specific PTEN knock-in alleviated urinary albumin and glomerular sclerosis in mice subjected to DKD [17]. Moreover, emerging evidence showed that PTEN was dysregulated in kidneys subjected to I/R injury, with abnormal PTEN expression driving cell-cycle progression and apoptosis of renal tubular cells [18, 19]. In cancer cells, PTEN reportedly regulates autophagosome biogenesis to preserve cellular integrity via PI3K/Akt/mammalian target of rapamycin signaling [20, 21]. Nevertheless, the role and mechanism of PTEN in autophagy and renal repair following acute injury remains far from clear. We hypothesized that PTEN protects the kidney against I/R-induced maladaptive repair by regulating autophagy flux.
Prior to formation of functional autolysosomes, lysosomes must be recruited and fused, which is triggered by a process where the inner and outer membranes of the autophagosome separates (phagophore closure). This process requires charged multivesicular bodies protein 2A (CHMP2A), an important component of endosomal sorting complexes for transport-III (ESCRT-III) [22, 23]. CHMP2A depletion, under both starved and non-starved conditions, causes accumulation of immature autophagosomal structures but not degradative autophagic structures (autolysosomes), reflecting an impairment of autophagy flux [22]. Nevertheless, no study to date has tested the role of CHMP2A-mediated autophagy flux in I/R-induced renal injury and repair.
To investigate the role of PTEN in I/R-induced renal maladaptive repair, we constructed mouse models where renal proximal tubular cells (RPTCs) specifically overexpressed PTEN and also cultured HK-2 cell models. Using mass spectrometry (MS)-based proteomics, we found that CHMP2A was significantly increased in RPTC-specific PTEN overexpression mice subjected to I/R. Further, we explored whether and how PTEN regulates autophagy flux via CHMP2A-mediated phagophore closure.
Results
PTEN was downregulated in renal tubular cells subjected to I/R-induced renal injury and maladaptive repair
Mice were subjected to bilateral renal artery obstruction for 15, 25, and 35 min, followed by 24 h reperfusion (BIRI). At 25 and 35 min obstruction, the level of serum creatinine (SCr) increased significantly, as compared to sham mice, consistent with the progressive renal tubular injury detected by hematoxylin and eosin (HE) staining (Fig. 1A, B and SFig. 1A). Immunoblotting and immunohistochemical analyses revealed that, at 25 and 35 min obstruction, I/R caused a significant decrease in PTEN expression (compared to sham mice) and an increased neutrophil gelatinase-associated lipocalin (NGAL) expression in the kidney, especially in tubule epithelial cells (Fig. 1B, C and SFig. 1B). Moreover, renal expression of PTEN negatively correlated with NGAL (r = −0.9416, 95% CI: −0.9713 to −0.8826; Fig. 1D).
In another set of experiments, mice were subjected to unilateral renal artery obstruction for 30 min, followed by 14 and 28 days of normal feeding (UIRI; SFig. 1C). In I/R-induced renal maladaptive repair mice (compared to sham mice), the level of SCr increased significantly at 14 and 28 days, consistent with progressive renal pathological changes (Fig. 1E and SFig. 1E, F). Fibrosis was obvious at 14 and 28 days post-I/R, as indicated by decreased kidney weight and increased Masson, Sirius red-positive staining, and levels of fibrotic proteins (Fig. 1F, G and SFig. 1D, E, G, H). Nevertheless, at 14 and 28 days post-I/R, PTEN protein expression in tubule epithelial cells declined progressively (Fig. 1F, G and SFig. 1I). Moreover, renal expression of PTEN negatively correlated with the levels of fibrotic proteins (fibronectin (FN): r = −0.9327; collagen I (Col-I): r = −0.8901; α-smooth muscle actin (α-SMA): r = −0.9060) (Fig. 1H).
RPTC-specific PTEN overexpression alleviated renal damage and apoptosis exposed to acute injury
PTEN was overexpressed in renal tubule epithelial cells by crossing PTENfl-stop-fl mice with Ggt1-Cre mice (Fig. 2A). The genotype PTENfl-stop-fl, Cre+/+ was confirmed by Northern blotting (Fig. 2B and SFig. 2A, B). In PTENfl-stop-fl, Cre+/+ mice, PTEN protein expression was significantly elevated in the kidney, especially tubules, as compared to other organs (Fig. 2C, D). In tubule epithelial cells, PTEN overexpression significantly reduced SCr level and alleviated renal tubule injury, as indicated by pathologic changes and NGAL protein expression (compared with PTENfl-stop-fl, Cre−/− mice subjected to I/R) (Fig. 2E, F, H and SFig. 2G). In addition, in I/R-induced PTENfl-stop-fl, Cre+/+ mice (compared to I/R-induced PTENfl-stop-fl, Cre−/− mice) the number of apoptotic renal tubule epithelial cells was markedly reduced (Fig. 2F, G).
RPTC-specific PTEN overexpression facilitated tubule regeneration and alleviated renal fibrosis in maladaptive repair
The overexpression of PTEN in tubule epithelial cells significantly reduced SCr level and the pathological damage of renal tubules and increased the kidney weight, compared to PTENfl-stop-fl, Cre−/− mice subjected to I/R-induced renal maladaptive repair (Fig. 3A–C and SFig. 2H). In addition, RPTC-specific PTEN overexpression increased proliferating cell nuclear antigen (PCNA) levels and E-cadherin re-expression and alleviated renal fibrosis, as indicated by reduced Masson and Sirius red-positive areas, as well as the levels of fibrotic proteins (Fig. 3C–E and SFig. 2I).
PTEN protected from damage and apoptosis in HK-2 cells subjected to I/R treatment
In HK-2 cells, when PTEN expression was reduced by antimycin A-mediated I/R stimulation, NGAL expression increased and cell viability decreased; and the response was dose-dependent (Fig. 4A, B). A reperfusion time-course study showed that, at 6 h reperfusion, PTEN expression levels decreased significantly; and then 24 h later, PTEN expression decreased gradually (by approximately half). Similarly, I/R caused a gradual increase in NGAL expression and decrease in cell viability, in a reperfusion time-dependent way (Fig. 4C, D). In I/R-stimulated HK-2 cells, PTEN knockdown increased NGAL expression and apoptosis and decreased cell viability. In contrast, PTEN overexpression protected HK-2 cells against I/R-induced cell damage and apoptosis (Fig. 4E–I).
Overexpression of PTEN affected phagosome, lysosome, and response to hypoxia in I/R condition
A heat map based on our MS data showed distinct patterns of protein expression in the kidney when comparing sham, BIRI, and BIRI + PTEN-OE (PTEN-OE was abbreviated for PTENfl-stop-fl, Cre+/+) mice (Fig. 5A). The Kyoto Encyclopedia of Genes and Genomes pathway combined with protein–protein interaction (PPI) analysis of differentially expressed proteins (DEPs) between BIRI and sham mice revealed that the DEPs were significantly enriched in pathways regulating the phagosome, hypoxia-inducible factor 1 (HIF-1) signaling, PI3K/Akt signaling, and interleukin-17 signaling (Fig. 5B, D). Moreover, DEPs between BIRI + PTEN-OE and BIRI mice were significantly enriched in pathways regulating the phagosome, PI3K/Akt signaling, HIF-1 signaling, and TGF-beta signaling (Fig. 5C, E). When comparing autophagy flux in I/R-treated HK-2 cells, we found that I/R caused a significant increase in the levels of LC3-II/LC3-I, accompanied with P62 accumulation. Nevertheless, bafilomycin A1 (Baf A1), an inhibitor of autophagy flux, failed to further increase LC3-II/LC3-I and P62 expression in I/R-treated HK-2 cells, indicating that autophagy flux was blocked in response to I/R (Fig. 5F and SFig. 3A). Interestingly, the heat maps of DEPs enriched in the phagosome, endocytosis, autophagy, and lysosome pathways indicated that CHMP2A, an autophagy flux-related protein, was significantly increased in BIRI + PTEN-OE mice compared to BIRI mice (Fig. 5G).
PTEN deficiency blocked phagosome closure via downregulating CHMP2A in HK-2 cells subjected to I/R treatment
Immunoblotting and immunofluorescence of HK-2 cells subjected to I/R revealed that PTEN knockdown significantly decreased the expression of CHMP2A and lysosome-associated membrane glycoprotein 1 (LAMP1) and accumulated autophagosome-bound LC3-II and P62 (Fig. 6A, B). Further, RFP-GFP-LC3 was applied to assess autophagy flux, to distinguish non-degradative (RFP+GFP+: yellow dots, reflecting autophagosomes) vs. degradative autophagic structures (RFP+GFP−: red dots, reflecting autolysosomes); and PTEN knockdown dramatically increased the number of RFP+GFP+ dots but not RFP+GFP− dots in I/R-treated HK-2 cells (Fig. 6C). Simultaneously, transmission electron microscope (TEM) revealed severe structural damage and an increased number of autophagosome in I/R-treated HK-2 cells in the presence of si-PTEN (Fig. 6D).
PTEN overexpression promoted phagosome closure by upregulating CHMP2A in HK-2 cells and mice subjected to I/R
In HK-2 cells subjected to I/R treatment, PTEN overexpression significantly increased CHMP2A and LAMP1 expression levels and attenuated the accumulation of autophagosome-bound LC3-II and P62 but accelerated autolysosome formation (as assessed by RFP-GFP-LC3 and TEM; Fig. 7A–D).
Consistently, in I/R mice, RPTC-specific PTEN overexpression caused a dramatic increase in CHMP2A and LAMP1 expression and a decrease in autophagosome-bound LC3-II and P62 (Fig. 7E, F). In addition, the number of autophagosomes was reduced, and autolysosome was observed in PTENfl-stop-fl, Cre+/+ mice (compared with PTENfl-stop-fl, Cre−/− mice exposed to I/R; Fig. 7G).
Silencing CHMP2A abolished the effect of PTEN on phagosome closure, independent of Akt signaling
In normal, cultured HK-2 cells, silencing CHMP2A increased the abundance of autophagosome-bound LC3-II and P62, without increasing the number of autolysosomes (Fig. 8A, B). In I/R-treated HK-2 cells, silencing CHMP2A aggravated the accumulation of autophagosome-bound LC3-II and P62 and elevated NGAL expression. Importantly, in the presence of si-CHMP2A, overexpression of PTEN failed to promote autophagy flux and reduce NGAL expression (Fig. 8A). Consistently, fluorescent RFP-GFP-LC3 showed that silencing CHMP2A significantly increased the number of autophagosomes (RFP+GFP+ dots) in the absence and presence of LV-PTEN, under control and I/R conditions (Fig. 8B). Additionally, CHMP2A was upregulated in I/R-treated HK-2 cells exposed to LV-PTEN rather than LY294002, an inhibitor of PI3K (Fig. 8C).
Discussion
Previous reports showed HIF-1α expression increases in response to I/R and that elevated levels of HIF-1α induce miR-21, miR-687, and other miRNAs that target PTEN in hypoxic/ischemic-treated tubular epithelial cells, inducing PTEN downregulation [18, 19, 24]. Other reports showed that, in aristolochic acid-induced kidney injury, activated nuclear factor-κB induces upregulation of miR-382, which targets the pten 3′-untranslated region, to downregulate PTEN protein levels [16]. In our study, after 15 min of kidney ischemia with renal adaptive repair, PTEN expression did not fall significantly; however, after 25 to 35 min of ischemia, PTEN did decrease significantly and renal repair became maladaptive. Consistent with these observations, in I/R-treated HK-2 cells exposed to antimycin A, PTEN levels were reduced and in a concentration-dependent manner. In addition, renal expression of PTEN negatively correlated with NGAL and fibrotic markers. This evidence suggests that PTEN protein levels, and their decrease in response to prolonged ischemia, were associated with the severity of renal injury and maladaptive repair.
Further, we demonstrated that RPTC-specific PTEN overexpression could alleviate acute renal injury and facilitate renal adaptive repair. Consistent with these data, PTEN knockdown aggravated injury and apoptosis in I/R-treated HK-2 cells, whereas PTEN overexpression restored I/R injury. In contrast, PTEN was proposed to be upregulated in kidney in I/R mice; and suppressing PTEN expression stimulated Akt phosphorylation and inhibited caspase-3 activation, triggering an anti-apoptotic effect [25, 26]. Here we propose that use of different mouse strains and the severity of injury might primarily explain the apparent contradiction in these data. During renal repair, there are two populations of tubules: one is impaired, with fibrotic tubules that fail to regenerate and redifferentiate, expressing little or no PTEN and showing expression of fibrotic genes; the other is composed of healthy tubules, plus impaired tubules, which regenerate and redifferentiate normally, and express increased levels of PTEN that extends beyond the foci of tubulointerstitial fibrosis [14, 15, 27]. Taken together, it appears that stable PTEN expression is essential for tubule epithelial cell regeneration and redifferentiation and that PTEN plays a renoprotective role in the early stage of AKI and during the progression of AKI to CKD.
To examine how PTEN protects against renal injury and maladaptive repair, we conducted MS-based proteomics comparing sham, BIRI, and BIRI + PTEN-OE mice and found that the autophagy pathway showed significant enrichment. In I/R-treated HK-2 cells, Baf A1 failed to further increase LC3-II/LC3-I and P62 levels. Notably, an increase in LC3B-II/LC3B-I can be attributed to either inhibition of autophagy flux or promotion of autophagosome biogenesis [28]. P62/SQSTM1, an autophagosome adapter, is continually degraded by the autolysosome but accumulates when autophagy flux is inhibited [29]. It was well acknowledged that, in I/R-AKI, autophagy is activated for scavenging and recycling of damaged macromolecules, which protects tubules from degeneration [30]. Nevertheless, accumulation of autophagosome-bound LC3-II and P62, and ubiquitin-positive cytoplasmic inclusions, increases apoptosis and oxidative stress and consequently exacerbates progression of AKI to CKD [31]. The above evidence suggests that, as a means to protect tubules from I/R injury and maladaptive repair, one strategy might be to enhance autophagy flux by targeting the autophagosome–autolysosome pathway, rather than stimulating autophagosome formation alone. Our study in HK-2 cells and mice showed that I/R caused autophagosome-bound LC3-II and P62 to accumulate, while autolysosomes did not accumulate. Overexpression of PTEN decreased the level of autophagosome-bound LC3-II and P62 and increased the level of autolysosomes, preventing P62 accumulation and attenuating I/R-induced cell damage; however, how PTEN is involved in autophagy flux in response to I/R remains unknown.
Using MS analysis, we profiled the autophagy-related proteins and discovered that CHMP2A was downregulated in BIRI, whereas RPTC-specific PTEN overexpression caused a significant increase in CHMP2A expression. CHMP2A is a member of the SNF7 family and is involved in protein sorting and transport from endosome to vacuole/lysosome [22]. CHMP2A is essential for annular fusion, including nuclear envelope formation of cell division, viral membrane abscission from infected cells, and autophagosome closure [22, 32, 33]. During autophagy, CHMP2A translocates to the phagophore and separates the inner and outer autophagosomal membranes to form double-membrane autophagosomes, a process required for autolysosome formation [22]. Notably, any unclosed autophagosomal membranes serve as a platform for intracellular death-inducing signaling complexes (iDISCs) [34]. Thus, silencing CHMP2A induces unclosed autophagosome-bound LC3-II and p62 accumulation and prevents lysosome recruitment and fusion by inhibiting phagophore closure, resulting in iDISC-mediated cell death [35]. These data suggest that a therapeutic approach might target autophagy at the step where autophagosomes become sealed and autolysosome form. Thus, CHMP2A may represent an attractive therapeutic target for maintaining cell integrity through promoting cytoprotective lysosomal degradation and alleviating iDISC-mediated apoptosis. Interestingly, the Genotype-Tissue Expression database (GTEx) showed a correlation between PTEN and CHMP2A in the kidney cortex (Pearson R = 0.6, P = 0.00065; SFig. 3B). In our study in HK-2 cells and mice subjected to I/R, PTEN overexpression boosted CHMP2A protein levels and this restored phagophore closure, resulting in reduced NGAL expression and apoptosis. Moreover, in I/R-treated HK-2 cells, silencing CHMP2A abolished the effect of PTEN on phagophore closure and cell damage.
How, then, does PTEN regulate CHMP2A expression? A key experiment using an inhibitor of PI3K, LY294002, showed that PTEN regulated CHMP2A independent of PI3K/Akt signaling. In addition, co-immunoprecipitation experiments found no evidence of any PPI between PTEN and CHMP2A (SFig. 3C). Interestingly, however, after I/R was induced in HK-2 cells, we found that nuclear PTEN expression was more significantly downregulated than cytoplasmic PTEN expression, suggesting that nuclear PTEN might play a pivotal role (data not shown). The translocation of PTEN to the nucleus is strongly associated with the function and activity of PTEN; and PTEN translocates to the nucleus in response to oxidative stress via activated ATM (ataxia telangiectasia mutated serine/threonine kinase)-mediated phosphorylation at serine 113 [12, 20, 36]. Once in the nucleus, PTEN activates the p-JUN-SESN2/AMPK pathway and thus induces autophagy [20, 36]. Our data together with previous reports suggest that cytoplasmic PTEN might be modified and then translocate to the nucleus where, under normal conditions, it regulates the transcriptional activity of CHMP2A. Moreover, low levels of cytoplasmic PTEN might, in turn, generate less nuclear translocation and finally reduce CHMP2A expression in I/R-exposed tissue. However, how PTEN precisely regulates CHMP2A requires further investigation.
Our data suggest that, during autophagy, CHMP2A translocates to the expanding autophagosomal membrane and regulates the separation of the inner and outer autophagosomal membranes and the formation of double-membrane autophagosomes. For functional autolysosomes to form, CHMP2A-mediated phagophore closure is critical because it prevents LAMP1 from being mislocalized to the inner autophagosomal membrane. Nevertheless, our work shows that, in response to I/R, PTEN was downregulated in RPTCs and downregulation of PTEN reduced CHMP2A protein levels, thus impairing ESCRT-mediated membrane abscission, resulting in accumulation of immature autophagosomal structures, cell injury, apoptosis, and fibrosis (Fig. 9).
Overall, our studies show that, if kidneys exposed to I/R-induced renal injury respond with maladaptive repair, then PTEN is downregulated; and this effect could be linked to the severity of I/R. However, RPTC-specific PTEN overexpression alleviated I/R-induced renal injury and improved renal maladaptive repair. Importantly, PTEN overexpression could promote autophagy flux by upregulating CHMP2A-mediated phagosome closure and thus attenuate cell injury and apoptosis in vivo and in vitro. This provides new insights into innovative, clinical applications that might target autophagy flux as a therapy for renal maladaptive repair.
Materials and methods
Transgenic mice
Transgenic B6.Cg-Tg(Ggt1-cre)M3Egn/J mice that expressed Cre recombinase under the control of gamma-glutamyltransferase 1 (Ggt1) promoter uniquely in cortical proximal tubules were purchased from The Jackson Laboratory [37]. Transgenic PTENfl-stop-fl mice were established as previously described [17]. Briefly, a transcriptional stop cassette, flanked by loxP recombination sites, was constructed before the recombinant PTEN coding region and inserted into the Rosa 26 locus, which allows overexpressing of PTEN upon introduction of the Cre recombinase. RPTC-specific PTEN overexpression mice were produced by crossing PTENfl-stop-fl mice with Ggt1-Cre mice, such that Cre-mediated recombination resulted in deletion of the transcriptional stop cassette and subsequent overexpression of PTEN in cortical tubular epithelium (genotype PTENfl-stop-fl, Cre+/+). PTENfl-stop-fl mice served as control mice (genotype PTENfl-stop-fl, Cre−/−). All animals were born at the expected Mendelian frequency, were normal in size, and did not display any gross physical or behavioral abnormalities (SFig. 2C–F). All animal experiments were approved by the Institutional Animal Care and Use Committee of Nanfang Hospital.
Mouse models of AKI and repair
AKI and repair was induced by renal I/R in male mice weighing ~22 g [38, 39]. In one set of mice, bilateral renal pedicles were clamped at the indicated times (15, 25, 35 min; n = 8 mice in each group) using microaneurysm clamps. After removal of clamps, kidney reperfusion was visually confirmed. During surgery, body temperature was maintained between 36 and 37 °C, using a temperature-controlled heating cushion (CINONTECH, China). Blood and tissue samples were obtained at 24 h reperfusion. In another set of mice, unilateral renal artery obstruction combined with contralateral uninephrectomy was utilized, and the resulting AKI repair was monitored. Briefly, left renal pedicle was clamped for 30 min and followed by reperfusion. Right kidney was excised at 13 or 27 days post-I/R. Blood and left kidney tissue were obtained at 14 or 28 days post-I/R (n = 8 mice in each group). In addition, PTENfl-stop-fl, Cre−/− and PTENfl-stop-fl, Cre+/+ mice were randomly assigned to the sham and BIRI/UIRI groups (n = 6 mice in each group).
HK-2 cell culture and treatment
A normal human proximal tubule epithelial cell line (HK-2, ATCC Cat# CRL-2190, RRID:CVCL_0302) was cultured in Dulbecco’s Modified Eagle Medium/F12 (Gibco) medium supplemented with 10% fetal bovine serum (Corning, USA) and 1% penicillin/streptomycin stock solution (10,000 U/ml). The I/R-induced HK-2 cell injury model was established by ATP/Glucose depletion [40]. In brief, when HK-2 cells were approximately 80% confluent, the culture medium was replaced with Hank’s Balanced Salt Solution (without Ca2+, Mg2+, 88284, Gibco) and then incubated with 80 µM antimycin A (Sigma) plus 10 mM 2-deoxy-d-glucose (HY-13966, MedChemExpress, MCE) for 1 h, to induce ischemic injury. In vitro reperfusion was achieved by incubating cells in complete growth medium.
Small interfering RNA (PTEN, CHMP2A) (RiboBio, China) was transfected at a final concentration of 50 nM using the Lipofectamine 3000 reagent (Invitrogen), according to the manufacturer’s instruction. PTEN was overexpressed via transfecting with a lentivirus incorporating PTEN recombinant plasmid (pHBLV-h-PTEN-3xflag-PURO, HANBIO, China), hereafter referred to as LV-PTEN. LV-NC, a lentivirus incorporating an empty plasmid, served as negative control. To generate RFP-GFP-LC3 HK-2 cells, HK-2 cells were transduced with lentiviruses encoding hU6-MCS-Ubiquitin-stubRFP-senseGFP-LC3-IRES-puromycin and selected with 1 µg/ml puromycin for 5 days. Baf A1 (100 nM, HY-100558, MCE) or LY294002 (10 μM, HY-10108, MCE) was added 2 h prior to I/R intervention and maintained until the end of the experiments.
Renal function analysis
SCr concentration was measured by an automated chemistry analyzer (AU480; Beckman Coulter, Brea, CA, USA).
Histology and immunohistochemical staining
Kidney samples were fixed in 10% neutral buffered formalin, paraffin-embedded, and sectioned at ~2–4 μm thickness prior to dewaxing and HE or Masson’s trichrome staining, according to the manufacturer’s protocols, respectively. Moreover, additional sections were used for immunohistochemical detection of PTEN. The percentage areas of fibrosis and positive protein immunostaining were quantified and calculated as the ratio of Masson and protein immunostaining-positive areas relative to the whole field (×400; % area), using Image-Pro Plus. This was performed by two individuals, blinded to group allocation. At least ten randomly chosen fields were evaluated for each mouse.
Analysis of apoptosis
Apoptosis was measured by terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL, Roche, USA) staining and Annexin V and propidium iodide-labeling flow cytometry (BD Biosciences, 556547), according to the manufacturers’ instructions. The apoptosis of tubule epithelial cells was assessed by determining the ratio of the number of TUNEL-positive tubular cells to the number of total cells. Flow cytometry was tested by BD LSR Fortessa, and data were analyzed by the FlowJO software. In addition, cell viability was determined by the Cell Counting Kit-8 Assay (DOJINDO, Japan) according to the manufacturer’s protocol.
Mass spectrometry
Using MS, the proteomic profile of renal tissue was compared in sham, BIRI mice (subjected to bilateral renal artery obstruction for 25 min, followed by 24 h reperfusion), and BIRI + PTEN-OE mice (PTENfl-stop-fl, Cre+/+ subjected to BIRI), following these steps: protein sample preparation, trypsin digestion, IBT labeling, high-performance liquid chromatography (HPLC) separation, and LC with tandem MS.
Western blotting analysis
Western blotting was performed as previously described [17]. The primary antibodies used were as follows: anti-PTEN (Abcam Cat# ab32199, RRID:AB_777535; Cell Signaling Technology Cat# 9188, RRID:AB_2253290; Proteintech Cat# 60300-1-Ig, RRID:AB_2881415), anti-NGAL (Abcam Cat# ab63929, RRID:AB_1140965), anti-FN (Sigma-Aldrich Cat# F3648, RRID:AB_476976), anti-Col-I (Boster Biological Technology Cat# BA0325, RRID:AB_2891224), anti-α-SMA (Sigma-Aldrich Cat# A5228, RRID:AB_262054), anti-PCNA (Proteintech Cat# Biotin-60097, RRID:AB_2883063), anti-E-Cadherin (Cell Signaling Technology Cat# 14472, RRID:AB_2728770), anti-Flag (Proteintech Cat# 20543-1-AP, RRID:AB_11232216), anti-CHMP2A (Proteintech Cat# 10477-1-AP, RRID:AB_2079470), anti-SQSTM1/p62 (Cell Signaling Technology Cat# 39749, RRID:AB_2799160), anti-LC3B (Cell Signaling Technology Cat# 83506, RRID:AB_2800018), anti-LAMP1 (Cell Signaling Technology Cat# 15665, RRID:AB_2798750), anti-β-tubulin (Tianjin Sungene Biotech Cat# KM9003, RRID:AB_2744678), and anti-GAPDH (Tianjin Sungene Biotech Cat# KM9002, RRID:AB_2721026). Western blotting was performed at least three times, independently. Quantification was performed by measuring the signal intensity using the software ImageJ (National Institutes of Health).
Immunofluorescence
For RFP-GFP-LC3 fluorescence, HK-2 cells transferred with RFP-GFP-LC3 virus on coverslips were washed 3 times with phosphate-buffered saline, fixed with 4% paraformaldehyde for 10 min, and mounted with 4,6-diamidino-2-phenylindole (DAPI). In addition, for LC3 and P62 two-color immunofluorescent staining, HK-2 cells on coverslips were fixed, permeabilized, and co-incubated with anti-LC3B and anti-P62 antibody at 4 °C overnight, followed by the corresponding Alexa Fluor secondary antibodies, and mounted with DAPI. Fluorescent images were obtained using an OLYMPUS IX81 deconvolution microscope (×63 oil-immersion lens).
Transmission electron microscope
Briefly, renal tissue or HK-2 cells were fixed in 2.5% glutaraldehyde, washed in cacodylate buffer, and postfixed in 1% osmium tetroxide. Specimens were then dehydrated, critical-point dried in carbon dioxide, and coated with atomic gold particles. Autophagic structures were observed using a TEM (Hitachi H-7500).
Statistical analysis
All data are presented as the mean ± SD. One-way analysis of variance followed by the Bonferroni multiple-comparison test was performed to compare parametric values among three or more groups. Correlation analysis between renal expression of PTEN and other parameters was performed using the Pearson Product-Moment Correlation. Statistical analysis of data was performed using Graph-Pad Prism 8.0 (Graph Pad Software, San Diego, CA). A P value <0.05 was considered statistically significant.
Data availability
All data generated or analyzed during this study are included in this published article and its Supplementary Information files.
References
Al-Jaghbeer M, Dealmeida D, Bilderback A, Ambrosino R, Kellum JA. Clinical decision support for in-hospital AKI. J Am Soc Nephrol. 2018;29:654–60.
Harris DG, McCrone MP, Koo G, Weltz AS, Chiu WC, Scalea TM, et al. Epidemiology and outcomes of acute kidney injury in critically ill surgical patients. J Crit Care. 2015;30:102–6.
Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13:241–57.
Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371:58–66.
Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 2015;26:1765–76.
Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7:189–200.
Linkermann A, Chen G, Dong G, Kunzendorf U, Krautwald S, Dong Z. Regulated cell death in AKI. J Am Soc Nephrol. 2014;25:2689–701.
Kaushal GP, Shah SV. Autophagy in acute kidney injury. Kidney Int. 2016;89:779–91.
Jiang M, Wei Q, Dong G, Komatsu M, Su Y, Dong Z. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int. 2012;82:1271–83.
Livingston MJ, Wang J, Zhou J, Wu G, Ganley IG, Hill JA, et al. Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys. Autophagy. 2019;15:2142–62.
Worby CA, Dixon JE. Pten. Annu Rev Biochem. 2014;83:641–69.
Lee YR, Chen M, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol. 2018;19:547–62.
Li Y, Hu Q, Li C, Liang K, Xiang Y, Hsiao H, et al. PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. J Clin Invest. 2019;129:1129–51.
Samarakoon R, Helo S, Dobberfuhl AD, Khakoo NS, Falke L, Overstreet JM, et al. Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses. J Pathol. 2015;236:421–32.
Lan R, Geng H, Polichnowski AJ, Singha PK, Saikumar P, McEwen DG, et al. PTEN loss defines a TGF-beta-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis. Am J Physiol Ren Physiol. 2012;302:F1210–1223.
Wang X, Xue N, Zhao S, Shi Y, Ding X, Fang Y. Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway. Cell death Dis. 2020;11:620.
Wang H, Feng Z, Xie J, Wen F, Jv M, Liang T, et al. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia. Am J Physiol Ren Physiol. 2018;314:F1096–F1107.
Bhatt K, Wei Q, Pabla N, Dong G, Mi QS, Liang M, et al. MicroRNA-687 induced by hypoxia-inducible factor-1 targets phosphatase and tensin homolog in renal ischemia-reperfusion injury. J Am Soc Nephrol. 2015;26:1588–96.
Pan T, Jia P, Chen N, Fang Y, Liang Y, Guo M, et al. Delayed remote ischemic preconditioning confers renoprotection against septic acute kidney injury via exosomal miR-21. Theranostics. 2019;9:405–23.
Chen JH, Zhang P, Chen WD, Li DD, Wu XQ, Deng R, et al. ATM-mediated PTEN phosphorylation promotes PTEN nuclear translocation and autophagy in response to DNA-damaging agents in cancer cells. Autophagy. 2015;11:239–52.
De Amicis F, Aquila S, Morelli C, Guido C, Santoro M, Perrotta I, et al. Bergapten drives autophagy through the up-regulation of PTEN expression in breast cancer cells. Mol Cancer. 2015;14:130.
Takahashi Y, He H, Tang Z, Hattori T, Liu Y, Young MM, et al. An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closure. Nat Commun. 2018;9:2855.
Zhen Y, Spangenberg H, Munson MJ, Brech A, Schink KO, Tan KW, et al. ESCRT-mediated phagophore sealing during mitophagy. Autophagy. 2020;16:826–41.
Liu X, Zhu N, Zhang B, Xu SB. Long noncoding RNA TCONS_00016406 attenuates lipopolysaccharide-induced acute kidney injury by regulating the miR-687/PTEN pathway. Front Physiol. 2020;11:622.
Vinas JL, Burger D, Zimpelmann J, Haneef R, Knoll W, Campbell P, et al. Transfer of microRNA-486-5p from human endothelial colony forming cell-derived exosomes reduces ischemic kidney injury. Kidney Int. 2016;90:1238–50.
Jia P, Teng J, Zou J, Fang Y, Zhang X, Bosnjak ZJ, et al. miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice. Anesthesiology. 2013;119:621–30.
Zhou X, Zang X, Ponnusamy M, Masucci MV, Tolbert E, Gong R, et al. Enhancer of zeste homolog 2 inhibition attenuates renal fibrosis by maintaining Smad7 and phosphatase and tensin homolog expression. J Am Soc Nephrol. 2016;27:2092–108.
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2021;17:1–382. (4th edition)(1)
Moscat J, Karin M, Diaz-Meco MT. p62 in cancer: signaling adaptor beyond autophagy. Cell. 2016;167:606–9.
Kimura T, Takabatake Y, Takahashi A, Kaimori JY, Matsui I, Namba T, et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol. 2011;22:902–13.
Kim DH, Park JS, Choi HI, Kim CS, Bae EH, Ma SK, et al. The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD. Cell Death Dis. 2021;12:320.
Van Engelenburg SB, Shtengel G, Sengupta P, Waki K, Jarnik M, Ablan SD, et al. Distribution of ESCRT machinery at HIV assembly sites reveals virus scaffolding of ESCRT subunits. Science. 2014;343:653–6.
Olmos Y, Hodgson L, Mantell J, Verkade P, Carlton JG. ESCRT-III controls nuclear envelope reformation. Nature. 2015;522:236–9.
Tang Z, Takahashi Y, Chen C, Liu Y, He H, Tsotakos N, et al. Atg2A/B deficiency switches cytoprotective autophagy to non-canonical caspase-8 activation and apoptosis. Cell Death Differ. 2017;24:2127–38.
Hattori T, Takahashi Y, Chen L, Tang Z, Wills CA, Liang X, et al. Targeting the ESCRT-III component CHMP2A for noncanonical Caspase-8 activation on autophagosomal membranes. Cell Death Differ. 2021;28:657–70.
Bassi C, Ho J, Srikumar T, Dowling RJ, Gorrini C, Miller SJ, et al. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science. 2013;341:395–9.
Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002;110:341–50.
Lech M, Rommele C, Grobmayr R, Eka Susanti H, Kulkarni OP, Wang S, et al. Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury. Kidney Int. 2013;83:647–61.
Xiao L, Zhou D, Tan RJ, Fu H, Zhou L, Hou FF, et al. Sustained activation of Wnt/beta-catenin signaling drives AKI to CKD progression. J Am Soc Nephrol. 2016;27:1727–40.
Xie J, Guo Q. Apoptosis antagonizing transcription factor protects renal tubule cells against oxidative damage and apoptosis induced by ischemia-reperfusion. J Am Soc Nephrol. 2006;17:3336–46.
Funding
This work was supported by grants from the National Natural Science Foundation of China (No. 81770727), GDUPS (2017), Key Project of Guangzhou Science Technology and Innovation Commission (201804020054), and the Natural Science Foundation of Guangdong (2021A1515011376).
Author information
Authors and Affiliations
Contributions
HW, YW, and XW performed the experiments and analyzed the data; JB, HH, and WZ assisted in collecting and analyzing the data; HW and AL designed the experiments and prepared the figures and the manuscript; all authors revised the manuscript and approved the final version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Professor Anastasis Stephanou
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, H., Wang, Y., Wang, X. et al. PTEN alleviates maladaptive repair of renal tubular epithelial cells by restoring CHMP2A-mediated phagosome closure. Cell Death Dis 12, 1087 (2021). https://doi.org/10.1038/s41419-021-04372-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-021-04372-6